B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Semaxanib

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Semaxanib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

ilorasertib
11 shared targets
pexidartinib
7 shared targets
sotuletinib
5 shared targets
vatalanib
8 shared targets
bemcentinib
7 shared targets
infigratinib
11 shared targets
maleimide
9 shared targets
hematoxylin
5 shared targets
lucitanib
6 shared targets
tivozanib
11 shared targets
Loading evidence profile...

This evidence profile for Semaxanib is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.